Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses
Advances in Therapy - United States
doi 10.1007/s12325-020-01247-8
Full Text
Open PDFAbstract
Available in full text
Date
February 20, 2020
Authors
Publisher
Springer Science and Business Media LLC